Correlation Between Halozyme Therapeutics and Legend Biotech
Can any of the company-specific risk be diversified away by investing in both Halozyme Therapeutics and Legend Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Halozyme Therapeutics and Legend Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Halozyme Therapeutics and Legend Biotech Corp, you can compare the effects of market volatilities on Halozyme Therapeutics and Legend Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Halozyme Therapeutics with a short position of Legend Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Halozyme Therapeutics and Legend Biotech.
Diversification Opportunities for Halozyme Therapeutics and Legend Biotech
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Halozyme and Legend is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Halozyme Therapeutics and Legend Biotech Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Legend Biotech Corp and Halozyme Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Halozyme Therapeutics are associated (or correlated) with Legend Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Legend Biotech Corp has no effect on the direction of Halozyme Therapeutics i.e., Halozyme Therapeutics and Legend Biotech go up and down completely randomly.
Pair Corralation between Halozyme Therapeutics and Legend Biotech
Given the investment horizon of 90 days Halozyme Therapeutics is expected to generate 0.9 times more return on investment than Legend Biotech. However, Halozyme Therapeutics is 1.11 times less risky than Legend Biotech. It trades about 0.03 of its potential returns per unit of risk. Legend Biotech Corp is currently generating about -0.01 per unit of risk. If you would invest 4,966 in Halozyme Therapeutics on November 9, 2024 and sell it today you would earn a total of 828.00 from holding Halozyme Therapeutics or generate 16.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Halozyme Therapeutics vs. Legend Biotech Corp
Performance |
| Timeline |
| Halozyme Therapeutics |
| Legend Biotech Corp |
Halozyme Therapeutics and Legend Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Halozyme Therapeutics and Legend Biotech
The main advantage of trading using opposite Halozyme Therapeutics and Legend Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Halozyme Therapeutics position performs unexpectedly, Legend Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will offset losses from the drop in Legend Biotech's long position.| Halozyme Therapeutics vs. Agios Pharm | Halozyme Therapeutics vs. Insmed Inc | Halozyme Therapeutics vs. Ultragenyx | Halozyme Therapeutics vs. Biomarin Pharmaceutical |
| Legend Biotech vs. Vaxcyte | Legend Biotech vs. Apellis Pharmaceuticals | Legend Biotech vs. Travere Therapeutics | Legend Biotech vs. Akero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |